Skip to content
  • About
    • Supporter
    • Expert Index
    • Editorial Board
    • Editorial Team
    • Editorial Policy
  • Contact
  • Sign up

Visit

vjneurology logo
VJDementia
Logo
  • Home (current)
  • Diseases
    Alzheimer's Disease
    Dementia
    Dementia with Lewy Bodies
    Frontotemporal Dementia
    Vascular Dementia
    Mild Cognitive Impairment
    View all Diseases
  • Topics
    Diagnostics
    Biology
    Communication
    Treatment
    Care Practice
    Prevention
    View all Topics
  • Conferences
    ARUK 2023
    CTAD 2022
    AAIC 2022
    EAN 2022
    ESOC 2022
    AAN 2022
    View all Conferences
  • Features
  • Podcasts
    • About
      • Supporter
      • Expert Index
      • Editorial Board
      • Editorial Team
      • Editorial Policy
    • Contact
    • Sign up

Milica Kramberger

Performance of plasma p-tau181 as a community-based screening tool for AD clinical trials 9:06
Performance of plasma p-tau181 as a community-based screening tool for AD clinical trials
Milica Kramberger • 21 Nov 2022
The value of plasma p-tau181 as a screening and diagnostic tool for Alzheimer’s disease 1:58
The value of plasma p-tau181 as a screening and diagnostic tool for Alzheimer’s disease
Milica Kramberger • 21 Nov 2022
Understanding the effect of other diseases on blood biomarker levels in AD 1:30
Understanding the effect of other diseases on blood biomarker levels in AD
Milica Kramberger • 21 Nov 2022
Journal Pages
  • Diseases
  • Topics
  • Medicines
  • Trials
  • Conferences
  • Features
Newsletter

Receive the latest news and videos from VJDementia via email

Sign up
Contact Us

Contact us for more information

mmp logo

Magdalen Centre
The Oxford Science Park
Oxford OX4 4GA, United Kingdom

VJDementia logo
The content of VJDementia is intended for healthcare professionals
  • Cookie Policy
  • Privacy Policy
  • Terms of Use
  • Editorial Policy